3,0
15 mei 2024
Huidige werknemer, meer dan 1 jaar
Cambridge, East of England, England
Aanbevelen
Goedkeuring directeur
Zakelijk vooruitzicht
Pluspunten
Really smart people Great facilities Interesting science
Minpunten
Has been described as a passive-aggressive organisation which is very true - hard to get things done People generally unhappy and disengaged, due to low pay, high workloads and little transparency from upper management Not the most innovative of Big pharma - content to fast follow and acquire late stage assets once validated rather than invest in their own original R&D Hard to get promoted and unclear what is required to progress